Join the 'Diabetes, Type 2' group to help and get support from people like you.

Diabetes, Type 2 Blog

Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2

Artificial Sweeteners May Raise Blood Sugar Levels: Study

Posted 7 hours ago by

WEDNESDAY, Sept. 17, 2014 – Diabetics and dieters who turn to artificial sweeteners to soothe their sweet tooth may not be doing themselves any favors, a new Israeli study suggests. Artificial sweeteners can potentially make blood sugar levels rise despite containing no calories, researchers found in human and mouse studies. That's because saccharine and its counterparts appear to alter the bacteria residing in the intestines in ways that can impair some people's ability to process glucose, the researchers report in the Sept. 17 issue of Nature. That means rather than helping the current epidemics of obesity and type 2 diabetes in the United States, artificial sweeteners could potentially be contributing to the problem, according to the study. The researchers found that mice fed artificial sweeteners developed higher blood sugar levels compared to mice drinking plain water or even ... Read more

Related support groups: Diabetes, Type 2, Pre-Diabetes

Combo Diabetes Therapy Outperforms Other Treatments, Study Finds

Posted 5 days ago by

FRIDAY, Sept. 12, 2014 – Combining insulin with a relatively new hormone-like drug appears to be a safer and more effective way to treat type 2 diabetes than current methods, a new review suggests. The drug belongs to a new class of injectable medications called "glucagon-like peptide-1 agonists" (GLP-1), which mimic the behavior of a gut hormone. It's already available as a treatment for diabetes, either used alone or in combination with basal insulin. But researchers say the current analysis is the first to confirm its superiority as part of a combined intervention. "The cornerstone of type 2 diabetes management is to try to get blood sugar levels as normal as possible," explained study author Dr. Ravi Retnakaran, an endocrinologist at Mount Sinai Hospital in Toronto. "Unfortunately, we have a lot of trouble getting there in most patients, because of the limitations and side effects ... Read more

Related support groups: Diabetes, Type 2

Diabetics Face Much Greater Risk of Heart Damage, Study Says

Posted 6 days ago by

THURSDAY, Sept. 11, 2014 – Using a new ultra-sensitive test, Johns Hopkins researchers found that people with diabetes may have a sixfold higher risk of heart failure even if their cholesterol is low and they appear otherwise healthy. Results of the new study suggest that people with diabetes and pre-diabetes may be suffering undetectable – but potentially dangerous – heart muscle damage, the researchers concluded. This heart damage is occurring regardless of a diabetic's cholesterol levels, which had no effect on test results, said lead author Elizabeth Selvin. She co-director of the Cardiovascular Epidemiology Training Program at the Johns Hopkins Bloomberg School of Public Health. "Even if we treat people with diabetes with statins, we may not be able to fully address the increased risk of death and heart failure in that population," Selvin said. "This underscores the need for ... Read more

Related support groups: Diabetes, Type 2, Heart Disease

Statins May Help Prevent Diabetes-Related Nerve Damage, Study Finds

Posted 7 days ago by

TUESDAY, Sept. 9, 2014 – Cholesterol-busting statins may also help prevent common and serious diabetes complications, a new study indicates. Although the drugs are known to lower the risk for heart attack and stroke among those with type 2 diabetes, Danish researchers report statins may also help protect against diabetes-related damage to small blood vessels in the body that can lead to blindness and amputations. The scientists noted that the results in the new research were unexpected. "Since high levels of blood glucose, the hallmark of diabetes, are linked with microvascular disease, and since statins are suspected of raising glucose levels, we tested the hypothesis that individuals taking a statin before a diagnosis of diabetes might be at increased risk of developing microvascular complications," study author Borge Nordestgaard, chief physician in clinical biochemistry at ... Read more

Related support groups: Diabetes, Type 2, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Rosuvastatin, Red Yeast Rice, Livalo, Pravachol, Lescol, Lescol XL, Mevacor, Altoprev, Pitavastatin, Baycol, Fluvastatin, Cerivastatin

Obesity Fueling Rise in Diabetes Rates, Study Finds

Posted 15 days ago by

TUESDAY, Sept. 2, 2014 – The U.S. obesity epidemic is a driving force behind the rising rates of type 2 diabetes, according to a new study. Researchers looked at data from five national surveys spanning from 1976 through 2010 to determine how much the increase in diabetes over time could be explained by factors such as changing distribution of race, age and obesity in U.S. adults. The investigators found that the prevalence of diabetes in men rose from about 5 percent to more than 11 percent. In women, it rose from under 6 percent to nearly 9 percent. When the researchers looked at factors that might contribute to rising diabetes rates, obesity stood out. Although for men, it only explained about half the increase, according to the researchers. "Overweight and obesity explained most of the increase in the prevalence of diabetes in the U.S. during this time period," said study ... Read more

Related support groups: Obesity, Diabetes, Type 2

Health Tip: Manage Stress to Keep Diabetes in Check

Posted 25 Aug 2014 by

-- Physical and emotional stress can be problematic for diabetics, as it tends to cause blood sugar to rise. The American Diabetes Association suggests how to keep stress under control: Find ways to reduce stress, such as by taking an alternate route to avoid traffic, mending problems with a friend or changing to a less stressful job. Engage in regular physical activity. Do something fun, such as taking dance lessons, picking up a new hobby or practicing a craft. Volunteer in your community. Practice relaxation exercises. Read more

Related support groups: Anxiety and Stress, Diabetes, Type 2

Low Birth Weights May Put Black Women at Risk for Diabetes

Posted 22 Aug 2014 by

THURSDAY, Aug. 21, 2014 – Being born at a low birth weight puts black women at increased risk for type 2 diabetes, a new study suggests. The findings may partly explain high diabetes rates among black Americans, a population that has a high prevalence of low birth weight, the researchers added. Their study of more than 21,000 black women found that those with a low birth weight were 13 percent more likely to develop type 2 diabetes than those with a normal birth weight. The risk of diabetes was 40 percent higher in those with a very low birth weight. Low birth weight was defined as less than 5.5 pounds and very low birth weight as less than 3.3 pounds. A woman's body weight did not appear to affect the link between low birth weight and increased diabetes risk. Those who weren't obese still had a higher risk of diabetes if they had a low or very low birth weight. While the study found ... Read more

Related support groups: Diabetes, Type 2

Getting Healthier a Big Money-Saver for People With Diabetes

Posted 21 Aug 2014 by

THURSDAY, Aug. 21, 2014 – Not only is eating better and exercising healthy for people with diabetes, it can save them hundreds of health-care dollars a year, a new study finds. The study, led by Mark Espeland, a professor of public health sciences at Wake Forest Baptist Medical Center in Winston-Salem, N.C., included more than 5,100 overweight and obese type 2 diabetes patients. Participants ranged in age from 45 to 76, and were randomly assigned to either an intensive "lifestyle change program" focused on diet and exercise, or to a standard diabetes support and education program. The patients in the lifestyle group had higher levels of physical activity and maintained a lower body weight, resulting in better diabetes control, blood pressure, sleep, physical function and fewer symptoms of depression, the team reported. There were financial savings, too. Over 10 years of follow-up, the ... Read more

Related support groups: Diabetes, Type 2

Health Tip: Reducing Your Chances of Heart Disease if You Have Diabetes

Posted 18 Aug 2014 by

-- Diabetics are at increased risk of developing heart disease, but there are lifestyle changes you can make to help lower the risk. The National Heart Lung and Blood Association explains how you can reduce the risk of diabetic heart disease: Maintain healthy cholesterol. Keep high blood pressure in check (under 130/80 mm/Hg). Don't smoke Lose any excess weight. Eat a diet low in sodium, sugar and saturated and trans fats. Get plenty of regular exercise. Find ways to manage stress. Read more

Related support groups: Diabetes, Type 2, Heart Disease

40 Percent of Americans Will Develop Diabetes, CDC Projects

Posted 12 Aug 2014 by

TUESDAY, Aug. 12, 2014 – Approximately two out of every five Americans will develop type 2 diabetes at some point during their adult lives, according to new U.S. government estimates. The ongoing diabetes and obesity epidemics have combined with ever-increasing human lifespans to increase lifetime risk of type 2 diabetes to about 40 percent for both men and women, said lead study author Edward Gregg, chief of the epidemiology and statistics branch in the division of diabetes translation at the U.S. Centers for Disease Control and Prevention (CDC). "We weren't necessarily surprised that it increased, but we didn't expect it to increase this much," Gregg said. "Forty percent is a humbling number." The odds are even worse for certain minority groups. Half of black women and Hispanic men and women are predicted to develop type 2 diabetes during their lifetime, the researchers reported. ... Read more

Related support groups: Obesity, Diabetes, Type 2

FDA Approves Invokamet (canagliflozin/metformin) for Type 2 Diabetes

Posted 11 Aug 2014 by

RARITAN, N.J., August 8, 2014 – Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved Invokamet, a fixed dose therapy combining canagliflozin and metformin hydrochloride in a single tablet, for the treatment of adults with type 2 diabetes. Invokamet provides the clinical attributes of Invokana (canagliflozin), the first sodium glucose co-transporter 2 (SGLT2) inhibitor available in the United States, together with metformin, which is commonly prescribed early in the treatment of type 2 diabetes. Invokamet is the first fixed-dose combination of an SGLT2 inhibitor with metformin approved in the United States. "Invokamet combines, in one tablet, two complementary therapeutic approaches proven effective for managing type 2 diabetes,” said Richard Aguilar, M.D.*, Medical Director of Diabetes Nation. "Canagliflozin works with the kidney to pro ... Read more

Related support groups: Diabetes, Type 2, Metformin, Invokana, Canagliflozin

Coaching May Help Diabetics Battle Depression, Disease Better

Posted 6 Aug 2014 by

WEDNESDAY, Aug. 6, 2014 – Mental health coaching may help diabetes patients with depression and with lowering their blood sugar levels, a new study suggests. Many people with diabetes suffer depression, which can interfere with their ability to manage their diabetes through monitoring blood sugar levels, being active, eating healthy and taking their medications, the researchers noted. This study included diabetes patients in a rural, low-income area of central North Carolina. Nearly 16 percent of people in this area have diabetes, compared with 10 percent of people nationally. Thirty percent of these diabetes patients have depression and 65 percent are poor, the study authors wrote. Researchers referred 182 patients with newly diagnosed type 2 diabetes and depression to a diabetes educator and also to a mental health coach, who helped them find ways to deal with the stresses and ... Read more

Related support groups: Depression, Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus

The 'Bear' Facts on Obesity and Diabetes

Posted 6 Aug 2014 by

TUESDAY, Aug. 5, 2014 – The ways grizzly bears deal with hibernation and fluctuating weight might offer valuable new clues to human obesity and diabetes, new research suggests. The study authors note that the tissues of obese people with type 2 diabetes become dangerously insensitive to insulin, the hormone that helps control the level of sugar in the blood. However, unlike people, insulin levels in grizzly bears do not change, the researchers found. Instead, the bears' cells seem to be able to control their ability to respond to insulin. In fact, in the fall – when grizzly bears are most obese – they are also the most sensitive to insulin, says a team led by Dr. Kevin Corbit, of the drug maker Amgen, Inc. According to Corbit's group, this happens because the activity of a key protein found in fat cells, called PTEN, is shut down. In fact, weeks into hibernation, grizzly bears ... Read more

Related support groups: Obesity, Diabetes, Type 2

Poor People With Diabetes Much More Likely to Lose a Limb: Study

Posted 4 Aug 2014 by

MONDAY, Aug. 4, 2014 – Poor people with diabetes are much more likely to lose a limb to the disease than affluent patients are, new research suggests. Researchers from the University of California, Los Angeles, found the odds of having a toe, foot or leg amputated was up to 10 times higher for diabetics who live in low-income neighborhoods. Most of these amputations are preventable if patients are diagnosed and get proper medical care sooner, the study authors noted. They added that their findings should prompt public officials to implement laws that help reduce barriers to health care. "When you have diabetes, where you live directly relates to whether you'll lose a limb to the disease. Millions of Californians have undergone preventable amputations due to poorly managed diabetes," lead author Dr. Carl Stevens, a clinical professor of medicine at the David Geffen School of Medicine at ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus

Jardiance Approved for Type 2 Diabetes

Posted 4 Aug 2014 by

FRIDAY, Aug. 1, 2014 – Jardiance (empagliflozin) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes, which accounts for some 90 percent of diabetes cases in the United States, the agency said Friday in a news release. Affecting some 26 million people in the United States, the disease can lead to complications including heart disease, blindness and nerve and kidney damage, the FDA said. Jardiance, from a class of drugs called "sodium glucose co-transporter 2 inhibitors," is designed to block re-absorption of blood sugar by the kidneys. Its safety and effectiveness were evaluated in clinical studies involving 4,480 people with type 2 diabetes. The drug should not be used to treat type 1 diabetes, in people with severe kidney impairment, among people with increased ketones in the blood or urine, or in people on dialysis, the FDA said. The agency said it ... Read more

Related support groups: Diabetes, Type 2

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Diabetic Ketoacidosis (in DM Type II), Diabetic Coma (in DM Type II), Diabetes Mellitus

Related Drug Support Groups

metformin, Victoza, Lantus, Januvia, Glucophage, glipizide, Novolog, Humalog, Byetta, view more... Welchol, Janumet, glyburide, Actos, Bydureon, Lantus Solostar, Levemir, glimepiride, Amaryl, bromocriptine, Onglyza, Novolin R, chromium picolinate, Avandia, Novolin N, pioglitazone, Humulin N, Invokana, Prandin, Glucophage XR, Humulin R, GlipiZIDE XL, Tradjenta, NovoLog FlexPen, Glucotrol, sitagliptin, ActoPlus Met, Symlin, acarbose, Glumetza, Humalog KwikPen, Humalog Pen, liraglutide, Glucotrol XL, gotu kola, Apidra, exenatide, insulin glargine, Glucovance, Novolin 70/30, Avandamet, Starlix, glyburide/metformin, NovoLog Mix 70/30, colesevelam, insulin regular, repaglinide, glipizide/metformin, linagliptin, Jentadueto, Humulin N Pen, Cycloset, Symlin Pen, Janumet XR, Novolin R PenFill, rosiglitazone, Apidra Solostar, saxagliptin, insulin lispro, Precose, miglitol, lavender, DiaBeta, nateglinide, Fortamet, Riomet, metformin/pioglitazone, Humalog Mix 75/25, Glynase, canagliflozin, ReliOn/Novolin 70/30, Humulin 70/30, glimepiride/pioglitazone, alogliptin/pioglitazone, SymlinPen 60, Exubera, Insulin Pork Mix, Humalog Mix 50/50 Pen, Novolin R Innolet, Iletin NPH, Novolin N PenFill, Novolin N Innolet, Lantus OptiClik Cartridge, Tanzeum, chlorpropamide, Oseni, Kombiglyze XR, insulin lispro/insulin lispro protamine, Nesina, alogliptin, PrandiMet, Kazano, Micronase, tolazamide, Humulin U, Juvisync, SymlinPen 120, Invokamet, Humalog Mix 50/50, acetohexamide, Humulin 50/50, insulin zinc, Humulin 70/30 Pen, Novolin 70/30 Innolet, Novolin 70/30 PenFill, Humalog Mix 75/25 Pen, NPH Insulin, insulin zinc extended, Farxiga, ReliOn/Novolin N, Humalog Mix 50/50 KwikPen, Novolog Mix 70/30 PenFill, NovoLog Mix 70/30 FlexPen, Jardiance, NovoLog PenFill, Humalog Mix 75/25 KwikPen, insulin isophane, ReliOn/Novolin R, Humulin R (Concentrated), Glyset, simvastatin/sitagliptin, linagliptin/metformin, insulin aspart, metformin/saxagliptin, metformin/repaglinide, glimepiride/rosiglitazone, tolbutamide, troglitazone, Tolinase, insulin aspart/insulin aspart protamine, insulin detemir, Diabinese, canagliflozin/metformin, empagliflozin, albiglutide, insulin inhalation, rapid acting, insulin glulisine, Lente Iletin II, Glycron, alogliptin/metformin, Metaglip, pramlintide, Duetact, Iletin II NPH Pork, Insulin Purified NPH Pork, dapagliflozin, Iletin Regular, Humulin L, Novolin L, metformin/sitagliptin, Iletin II Lente Pork, Iletin Lente, Insulin Lente Pork, Velosulin BR, Iletin II Regular Pork, Glynase PresTab, Dymelor, insulin isophane/insulin regular, Avandaryl, Orinase, Tol-Tab, Chromium GTF, Cr-GTF, Rezulin, metformin/rosiglitazone